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Objective: Residual subclavian vein stenosis after thoracic outlet decompression in patients with venous thoracic outlet
syndrome is often treated with postoperative percutaneous angioplasty (PTA). However, interval recurrent thrombosis
before postoperative angioplasty is performed can be a vexing problem. Therefore we initiated a prospective trial at 2
referral institutions to evaluate the safety and efficacy of combined thoracic outlet decompression with intraoperative
PTA performed in 1 stage.
Methods: Over 3 years 25 consecutive patients (16 women, 9 men; median age, 30 years) underwent treatment for venous
thoracic outlet syndrome with a standard protocol at 2 institutions. Twenty-one patients (84%) underwent preoperative
thrombolysis to treat axillosubclavian vein thrombosis. First-rib resection was performed through combined supracla-
vicular and infraclavicular incisions. Intraoperative venography and subclavian vein PTA were performed through a
percutaneous basilic vein approach. Postoperative anticoagulation therapy was not used routinely. Venous duplex
ultrasound scanning was performed postoperatively and at 1, 6, and 12 months.
Results: Intraoperative venography enabled identification of residual subclavian vein stenosis in 16 patients (64%), and all
underwent intraoperative PTA with 100% technical success. Postoperative duplex scans documented subclavian vein
patency in 23 patients (92%). Complications included subclavian vein recurrent thrombosis in 2 patients (8%), and both
underwent percutaneous mechanical thrombectomy, with restoration of patency in 1 patient. One-year primary and
secondary patency rates were 92% and 96%, respectively, at life-table analysis.
Conclusions: Residual subclavian vein stenosis after operative thoracic outlet decompression is common in patients with
venous thoracic outlet syndrome. Combination treatment with surgical thoracic outlet decompression and intraoperative
PTA is a safe and effective means for identifying and treating residual subclavian vein stenosis. Moreover, intraoperative
PTA may reduce the incidence of postoperative recurrent thrombosis and eliminate the need for venous stent placement
or open venous repair. ( J Vasc Surg 2004;40:599-603.)Primary axillary-subclavian vein thrombosis, or venous
thoracic outlet syndrome, is a relatively uncommon but
potentially disabling condition that affects young and oth-
erwise healthy persons. Treatment with anticoagulation
therapy alone is suboptimal, resulting in some degree of
chronic disability in as many as 70% of patients.1-4 In
contrast, there is growing consensus that early diagnosis
and thrombolytic therapy followed by operative first-rib
resection produces the most favorable long-term outcome
for the patient.5-7 Whereas surgical treatment is often de-
layed for several months after thrombolysis, it is now clear
that successful subclavian vein thrombolysis may be fol-
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doi:10.1016/j.jvs.2004.07.028lowed immediately by operative thoracic outlet decompres-
sion during a single hospitalization.8,9 The potential advan-
tages of such an expedient strategy are that the period of
anticoagulation is shortened, patients may return more
rapidly to normal activity, and the risk for recurrent throm-
bosis is reduced.
Despite successful subclavian vein thrombolysis and tho-
racic outlet decompression, residual subclavian vein stenosis
due to an intrinsic vein lesion is common.10-12 The available
options for treating intrinsic subclavian vein lesions include
open venolysis, patch angioplasty, or venous bypass at the time
of thoracic outlet decompression or percutaneous translumi-
nal angioplasty (PTA) or stent placement postoperatively.
Most treatment algorithms now advocate that PTA be per-
formed several days to 1 month after surgical decompres-
sion.7,9,10 However, delaying treatment of residual subclavian
vein stenosis may increase the risk for recurrent thrombosis in
the postoperative period.
We hypothesized that residual subclavian vein stenosis
can be safely and effectively treated with intraoperative PTA
at the time of operative thoracic outlet decompression,
thereby eliminating any flow-limiting lesion and minimiz-
ing the risk for postoperative recurrent thrombosis. This599
JOURNAL OF VASCULAR SURGERY
October 2004600 Schneider et alstudy prospectively evaluated this 1-stage treatment algo-
rithm for venous thoracic outlet syndrome with clinical and
objective duplex ultrasound follow-up of subclavian vein
patency.
PATIENTS AND METHODS
Over 3 years 25 consecutive patients (16 women, 9
men; median age, 30 years) underwent treatment of venous
thoracic outlet syndrome with a standard protocol at 2
institutions. Patients with acute subclavian vein thrombosis
or symptomatic subclavian vein stenosis were included in
the study, and patients with chronic (4 weeks) subclavian
vein occlusion were specifically excluded. All patients had
clinical symptoms, including arm swelling in 100% and arm
pain or a sensation of arm heaviness in 21 of 25 patients
(84%). Twenty-three of 25 patients (92%) had acute sub-
clavian vein thrombosis, and the remaining 2 patients (8%)
had severe subclavian vein stenosis without thrombosis. Of
the 23 patients with subclavian vein thrombosis, thrombus
was limited to the subclavian and axillary veins in 21 pa-
tients (91%), and 2 patients (9%) had extensive upper
extremity thrombosis with involvement of the subclavian,
axillary, basilica, and brachial veins. In total, 21 patients
(84%) underwent preoperative thrombolysis to treat axillo-
subclavian vein thrombosis. Seven of 21 patients (28%)
with axillosubclavian vein thrombosis underwent throm-
bolysis at our institutions, followed by immediate surgical
decompression without an intervening period of anticoag-
ulation therapy. Fourteen of 21 patients (56%) underwent
thrombolysis at other institutions before referral to our
institutions; therefore these patients underwent delayed
surgical decompression after a variable period of anticoag-
ulation with warfarin sodium (mean delay, 2.2 months;
range, 0.5-7 months). An additional 2 patients (8%) with
acute subclavian vein thrombosis received treatment at
other institutions, with anticoagulation alone without
thrombolysis, and spontaneous recanalization of the sub-
clavian vein was confirmed at venography before operation
(Table I).
Positional venograms documenting compression of the
subclavian vein with arm abduction were used to establish
the diagnosis of venous thoracic outlet syndrome and to
confirm patency of the subclavian vein in all patients before
operation. Venography of the contralateral, unaffected ex-
tremity was not performed routinely. All patients under-
Table I. Patient presentation and initial treatment
No. of
patients
Subclavian vein thrombosis 23
Thrombolysis 21
Immediate operation* 7
Delayed operation† 14
Anticoagulation therapy only 2
Subclavian vein stenosis without thrombosis 2
*Surgical decompression performed less than 24 hours after thrombolysis.
†Surgical decompression performed more than 24 hours after thrombolysis.went surgical thoracic outlet decompression under general
endotracheal anesthesia. The first 23 consecutive opera-
tions (92%) included first-rib resection, with anterior and
middle scalenectomy performed through a paraclavicular
approach with combined supraclavicular and infraclavicular
incisions.13 The last 2 patients (8%) underwent first-rib
resection through a single infraclavicular incision. In all
patients the costoclavicular space was completely decom-
pressed by anterior division of the first rib at the costoster-
nal junction. In some patients, when indicated by operative
findings, subclavian vein venolysis was performed, but di-
rect subclavian vein repair or bypass was not performed in
any patients. Closed suction drains were left in all patients.
At completion of surgical decompression all 25 patients
underwent venography with digital subtraction fluoros-
copy in the operating suite. The basilic vein in the distal arm
was catheterized under ultrasound guidance, and venogra-
phy was performed with the arm in both adducted and
abducted positions to confirm that positional subclavian
compression was relieved with surgical decompression. In
patients with residual subclavian vein stenosis (50%) PTA
was performed with standard techniques. PTA was per-
formed with 10-mm, 12-mm, or 14-mm angioplasty bal-
loons, and high-pressure balloon inflation up to 20 atm was
used when necessary. Heparin was selectively administered
in some patients during PTA, at the discretion of the
surgeon. Completion venography after PTA was performed
in both adducted and abducted positions to confirm the
adequacy of thoracic outlet decompression and subclavian
vein PTA. Patients were given daily aspirin therapy, and did
not routinely receive anticoagulation therapy postopera-
tively. According to a prospective surveillance protocol,
duplex ultrasound scanning was performed before hospital
discharge and at 1, 6, and 12 months postoperatively.
Patency data was analyzed with the life table method.14
RESULTS
All 25 patients underwent intraoperative venography
after surgical decompression. Persistent subclavian vein ste-
nosis was identified on venograms in 16 patients (64%)
(Figs 1 and 2). All 16 patients with residual subclavian vein
stenosis underwent PTA, with a 100% technical success
rate, defined as less than 30% residual stenosis and de-
creased or absent collateral vein filling. Completion venog-
raphy performed with the arm in both the adducted and
abducted positions confirmed successful surgical decom-
pression, defined by absence of positional subclavian vein
compression in all patients. Venous stents were not placed
in any patients.
There were no deaths. Complications included
wound hematoma requiring repeat exploration in 3 pa-
tients (12%), postoperative subclavian vein rethrombosis
in 2 patients (8%), and phrenic nerve dysfunction in 1
patient (4%). All 3 patients in whom wound hematomas
developed had received intravenous heparin during the
operation, to prevent thrombosis of severe subclavian
vein stenoses. Both patients with postoperative subcla-
abdu
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erative PTA for treatment of persistent subclavian vein
stenosis. In addition, both patients had initially had
extensive upper extremity venous thrombus, including
thrombosis of the brachial basilic veins. Postoperative
recurrent thrombosis in both patients was treated with
percutaneous mechanical thrombectomy with an Angio-
Jet device (Possis), with successful restoration of venous
patency in 1 patient. Twenty-four of 25 patients (96%)
Fig 1. Right upper extremity venograms in a 19-year-o
that was treated with heparin, with spontaneous su
A, Preoperative venogram during arm abduction demo
multiple venous collateral vessels. B, Intraoperative v
decompression shows subclavian vein stenosis with resid
with 12-mm balloon demonstrates widely patent subclav
Fig 2. Left upper extremity venograms. A, Preopera
subclavian vein stenosis within the costoclavicular space
demonstrates widely patent subclavian vein with the armhad patent subclavian veins at hospital discharge, as
demonstrated on duplex ultrasound scans. Four patients
(16%) were discharged with warfarin therapy, including
both patients with postoperative recurrent thrombosis
and an additional 2 patients with nonocclusive subcla-
vian vein thrombus that was detected on postoperative
duplex ultrasound scans. The remaining 21 patients
(84%) were discharged with daily aspirin without post-
operative warfarin therapy.
man with a history of right subclavian vein thrombosis
ian vein recanalization documented at venography.
es positional occlusion of the right subclavian vein and
am in the same patient after surgical thoracic outlet
hronic thrombus. C, Completion venogram after PTA
ein with the arm abducted.
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follow-up in 19 patients (76%) and 1-year follow-up in 12
patients (48%). One-year primary and secondary subclavian
vein patency was 92% and 96%, respectively, at life table
analysis (Tables II and III). The patient with an occluded
subclavian vein at discharge received warfarin therapy, and
spontaneous vein recanalization was confirmed at Duplex
ultrasound examination 6 months later. All patients dis-
charged with a patent subclavian vein (96%) experienced
durable relief of arm swelling and pain.
DISCUSSION
The goal of treatment of venous thoracic outlet syn-
drome is to achieve durable subclavian vein patency to avert
chronic disability from persistent venous obstruction and
hypertension. There is growing consensus that early diag-
nosis followed by thrombolysis and operative thoracic out-
let decompression restores venous patency and relieves
extrinsic venous compression, achieving the most favorable
results.5,7-10,15 However, thoracic outlet decompression
does not directly address intrinsic subclavian vein stenosis
caused by injury of the vein from chronic compression.
These residual intrinsic lesions of the subclavian vein are
not uncommon, and by impeding flow are presumed to be
the cause of treatment failure due to recurrent venous
thrombosis.16
As an adjunct to operative thoracic outlet decompres-
sion, catheter-based approaches for treatment of persistent,
intrinsic subclavian vein stenoses have become popu-
lar.6,10,12 Of importance, PTA is not a substitute for oper-
ative thoracic outlet decompression, and is ineffective in
this regard.8,10,17 Stent placement in lieu of surgery has also
been attempted, with little success because stents are sub-
ject to compression between the clavicle and first rib, which
often results in stent fracture and frequent subclavian recur-
rent thrombosis.18,19 However, PTA and possibly stent
placement are effective means of eliminating persistent
Table II. Life table of primary subclavian vein patency
Interval
(mo)
No. at risk
at beginning
of interval
No. failed
during
interval
No
dur
0-1 25 2
1-3 23 0
3-6 20 0
6-12 19 0
Table III. Life table of secondary subclavian vein patency
Interval
(mo)
No. at risk
at beginning
of interval
No. failed
during
interval
No.
duri
0-1 25 1
1-3 24 0
3-6 21 0
6-12 20 0subclavian vein stenosis after operative thoracic outlet de-
compression has been performed.12
It appears reasonable to infer that persistent stasis due
to a flow-limiting subclavian vein lesion in combination
with the local trauma of thoracic outlet decompression may
create a prothrombotic milieu in the early postoperative
period. Indeed, before this study several of our patients
experienced recurrent thrombosis during the 3-day waiting
period before performance of venography and PTA of
persistent subclavian stenosis. We reasoned that by combin-
ing surgical thoracic outlet decompression and intraopera-
tive PTA into a 1-stage operation we could promptly
eliminate both the extrinsic and the intrinsic subclavian vein
stenosis, thereby reducing stasis and minimizing the risk for
postoperative recurrent thrombosis. The results of this
study suggest that intraoperative angioplasty may substan-
tially reduce this common mode of treatment failure.
We identified persistent subclavian vein stenosis in
more than 60% of our patients, and found that PTA used
alone is an effective means of treating persistent subclavian
vein stenosis after thoracic outlet decompression. In con-
trast, Kreienberg et al12 reported placement of venous
stents in 61% of their patients after PTA alone failed to
eliminate persistent subclavian vein stenoses. This discrep-
ancy in part reflects our bias against placement of venous
stents in the subclavian veins in young, otherwise healthy
persons. In our experience balloon inflation pressures in
excess of 10 atm are occasionally necessary to successfully
dilate the fibroelastic subclavian vein lesions that are com-
monly present in patients with venous thoracic outlet syn-
drome. Moreover, high rates of failure of subclavian vein
stents have been reported, perhaps because of the mobility
of the shoulder joint and of the axillary and subclavian
veins.20,21 Because the long-term durabilty of subclavian
vein stents remains to be defined and there have been
numerous reports of high rates of recurrent stenosis, occlu-
sion, and need for repeat intervention after placement of
drawn
nterval
Interval
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rate
Cumulative
patency rate
(%) SE (%)
0.08 92.00 5.20
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rawn
terval
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0
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stent placement in our patients.21-23 The absence of sub-
clavian vein recurrent thrombosis during follow-up after
thoracic outlet decompression and PTA further supports
avoidance of stents in favor of PTA alone in patients with
persistent subclavian vein stenosis after thoracic outlet de-
compression. However, longer follow-up is necessary to
confirm the durability of subclavian vein PTA in patients
with venous thoracic outlet syndrome.
Our current preference is to perform thoracic outlet
decompression immediately after successful thrombolysis,
which is safe and effective.8,9 While it is our preference to
perform immediate operation after thrombolysis, it must be
emphasized that approximately half of the patients in this
series underwent thrombolysis at delayed surgical decom-
pression after thrombolysis performed at other institutions,
because of regional referral practices. It should also be
noted that 2 patients in our series had subclavian vein
stenoses without subclavian vein thrombosis, and these
patients may have been at lower risk for recurrent throm-
bosis. Nonetheless, when possible, we combine the treat-
ment of venous thoracic outlet syndrome into a 1-stage
protocol, with immediate operation, including intraopera-
tive venography, and PTA during a single hospitalization.
This shortens the duration of treatment, permits earlier
return of patients to normal activity, and eliminates the
need for prolonged anticoagulation therapy.
Before this study we reported treatment of subclavian
stenosis during surgical thoracic outlet decompression, with
open circumferential venolysis and patch angioplasty of the
subclavian vein, if necessary. Residual stenosis was treated
postoperatively with percutaneous angioplasty in 4 of 24
patients. In the context of acute subclavian vein thrombosis,
this resulted in durable patency and symptom relief without
routine use of anticoagulation therapy postoperatively.7 Like-
wise, in the current study we found routine use of postopera-
tive anticoagulation therapy unnecessary after combined open
decompression and intraoperative PTA. Currently we reserve
postoperative anticoagulation therapy for patients with recur-
rent subclavian vein recurrent thrombosis and patients with
evidence of residual subclavian vein thrombus on postopera-
tive duplex ultrasound scans.
In conclusion, the findings of this study suggest that
combination treatment of venous thoracic outlet syndrome
with intraoperative venography and PTA is a safe, efficient,
and effective method of identifying and treating residual
subclavian vein stenosis after operative thoracic outlet de-
compression. Residual subclavian vein stenosis is com-
monly present after operative thoracic outlet decompres-
sion, and may be effectively managed with PTA alone.
Subclavian vein stent placement is rarely indicated, and
routine placement of subclavian vein stents in patients with
venous thoracic outlet syndrome should be discouraged.
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